Results

Total Results: 2,327 records

Showing results for "responses".

2021. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
      September 01, 2011 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible … This study suggests that VNS has a slow onset of response, but that responses are durable, and that

2022. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
      June 16, 2010 - A summary of relevant comments and our responses follow each key question; general comments applying … to all key questions and responses are listed after the last key question. … events including those related to red blood cell transfusion Intermediate outcomes: • hematologic responses

2023. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
      December 16, 2014 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing on … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible for

2024. McCullough (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/mccullough.pdf
      January 01, 2011 - management: clinical ethical tool for responsibly managing uncertainty about plan of care o Candor-­‐based responses

2025. Template for Reports Developed (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
      October 26, 2012 - Template for Reports Developed Future Research Needs Paper Number 17 Future Research Needs for Prevention and Treatment of Clostridium difficile Infection Future Research Needs Paper Number 17 Future Research Needs for Prevention and Treatment of Clostridium difficile Infection Identification o…

2026. Medical Therapies for Children With Autism Spectrum Disorder—An Updaterum Disorder--An Update (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/asd-medical-disposition.pdf
      May 26, 2017 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing on … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible for

2027. Arthritis and Nontraumatic Joint Disease (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
      June 01, 2015 - significant improvement in American College of Rheumatology criteria for 20% improvement (ACR20) responses … 66.3%, and 32.6%, and patients whose symptoms did not respond to previous TNF treatment had ASAS20 responses … patients who received secukinumab 75 mg did not have significant improvements in ASAS20 or ASAS40 responses … Using an observed analysis, patients treated with secukinumab 75 mg had ACR 20/50/70 responses of 66.9%

2028. Data-Points-6-Tables (xls file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-6-tables.xls
      January 01, 2006 - 1 Number of Beneficiaries With at Least One Part A, B, or D Drug Claim for a Biologic of Interest (among continuously enrolled AB FFS population) by Class of Drug and Active Ingredient, 2006-2009 Note: A single period (.) signifies a small cell count (less than 11). Use filters to rank by beneficiary count. …

2029. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
      March 13, 2012 - and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses

2030. The purpose of our tool is to compile a comprehensive list of questions that may be used to evaluate the quality of non-randomized studies of interventions or exposures (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/reliability-testing-grading-evidence_research.pdf
      May 01, 2012 - completed each of the exercises; subsequently, each pair of reviewers reconciled their independent responses … the 10 exercises; subsequently, the two reviewers—i.e., the ―pair‖—reconciled their independent responses … We assigned a numeric value to each of the domains/strength of evidence responses for each reviewer … Agreement improved to fair (AC1=0.22) among pairs of reviewers for the reconciled responses. … Reconciliation Across Reviewer Pairs We received responses from 8 of the 11 pairs describing the approach

2031. Ebctandcfinal (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/ebctandcfinal.pdf
      June 05, 2012 - AHRQ Evidence-Based Care (EBC) Challenge Terms and Conditions Terms and Conditions: By submitting a product in response to the AHRQ Evidence-Based Care (EBC) Challenge, each team and each team member represents and warrants that:  The team and its members are the sole authors, creators, and owners of the pr…

2032. Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
      January 07, 2016 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing on … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible for

2033. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
      March 10, 2010 - Comments on draft reviews and the authors’ responses to the comments will be posted publicly on the

2034. Hit-Patient-Care Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hit-patient-care_executive.pdf
      June 01, 2012 - Evidence-Based Practice Evidence-based Practice Program The Agency for Healthcare Research and Quality (AHRQ), through its Evidence- based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to imp…

2035. Discerning the Perception and Impact of Patients Involved in Evidence-based Practice Center Key Informant Interviews (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/key-informant-interviews-research.pdf
      December 19, 2017 - • “I think it behooves people who are conducting the interview to have some really good responses … that let the person who is responding know that no matter what they 14 say, their responses … Data will be assessed individually and then will be compared and contrasted to the responses the EPC … (2) All audio recordings, transcripts, and background questionnaire responses will be stored on a … All responses will be provided in summary form and will not indicate who said what.

2036. Pneumonia-Antibiotic-Treatment Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
      November 01, 2014 - risk of bias) that used PK/PD measures to study the impact of different antibiotic dosing on clinical responses

2037. Cancer-Drugs-Utilization-Cost Research (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
      January 01, 2011 - Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Data Points #6Anticancer Biologics From 2006 to 2009, over 800,000 Medicare fee-for-service beneficiaries continuously enrolled in Parts A and B had a claim for an anticancer biologic of interest. Bevacizumab was the m…

2038. • Identify disparities and reasons for disparities and reevaluate the framework for researching disparities The following article was used in answering this question: Davis, L. M., Kilburn, M. R., and Schultz, D. (2009). Reparable Harm:… | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/identify-disparities-and-reasons-for-disparities-and-reevaluate-the-framework-for-researching-disparities-the-following-article-was-used-in-answering-this-question-davis-l-m-kilburn-m-r-and-schultz-d-2009-reparable-harm-asse
      November 01, 2017 - subgroups of patients (e.g., age, race, and common comorbidities) to identify variation in patient responses

2039. Phenylketonuria Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
      February 01, 2012 - Overall, participants’ responses to different dosages of BH4 varied, with individualized dose adjustments

2040. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
      November 22, 2011 - Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel … evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses